- Home
- ICLR vs UNM Comparison
ICLR vs UNM Comparison
Compare ICLR & UNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- UNM
- Stock Information
- Founded
- ICLR 1990
- UNM 1848
- Country
- ICLR Ireland
- UNM United States
- Employees
- ICLR N/A
- UNM N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- UNM Accident &Health Insurance
- Sector
- ICLR Health Care
- UNM Finance
- Exchange
- ICLR Nasdaq
- UNM Nasdaq
- Market Cap
- ICLR 14.3B
- UNM 12.7B
- IPO Year
- ICLR 1998
- UNM 1986
- Fundamental
- Price
- ICLR $162.73
- UNM $76.81
- Analyst Decision
- ICLR Buy
- UNM Buy
- Analyst Count
- ICLR 15
- UNM 12
- Target Price
- ICLR $205.07
- UNM $94.67
- AVG Volume (30 Days)
- ICLR 963.3K
- UNM 1.5M
- Earning Date
- ICLR 10-22-2025
- UNM 11-03-2025
- Dividend Yield
- ICLR N/A
- UNM 2.39%
- EPS Growth
- ICLR N/A
- UNM N/A
- EPS
- ICLR 7.47
- UNM 5.18
- Revenue
- ICLR $8,102,602,000.00
- UNM $13,068,000,000.00
- Revenue This Year
- ICLR N/A
- UNM $3.91
- Revenue Next Year
- ICLR $0.89
- UNM $3.05
- P/E Ratio
- ICLR $21.70
- UNM $14.87
- Revenue Growth
- ICLR N/A
- UNM 2.13
- 52 Week Low
- ICLR $125.10
- UNM $66.81
- 52 Week High
- ICLR $228.29
- UNM $84.48
- Technical
- Relative Strength Index (RSI)
- ICLR 40.46
- UNM 52.28
- Support Level
- ICLR $155.00
- UNM $76.27
- Resistance Level
- ICLR $167.43
- UNM $78.00
- Average True Range (ATR)
- ICLR 6.33
- UNM 1.82
- MACD
- ICLR -0.64
- UNM 0.14
- Stochastic Oscillator
- ICLR 30.91
- UNM 67.55
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About UNM Unum Group
Unum Group is a provider of group and individual income protection insurance products in the United States, the United Kingdom, Poland, and other countries. It is the domestic disability insurer, with the majority of premiums generated from employer plans. The company also offers a complementary portfolio of other insurance products, including long-term care insurance, life insurance, and employer- and employee-paid group benefits. It has the following operating business segments: Unum USA, Unum International, Closed Block, Colonial Life, and Corporate. The majority of the revenue is earned from the Unum USA segment. The firm markets its products through brokers.